Norway - Antihypertensive Medicine Use
Since 2014, Norway Antihypertensive Medicine Use was down by 9.4% year on year. In 2019, the country was ranked number 26 among other countries in Antihypertensive Medicine Use with 2.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Norway is overtaken by Chile, which was ranked number 25 with 2.6 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by South Korea at 1.8 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Hungary lead the ranking with 34.8 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, a growth of 4.2% versus 2018. Lithuania, Slovakia and Slovenia respectively ranked number 2, 3 and 4 in this ranking. Canada witnessed the best average annual growth at +10.3% per year, while Slovakia recorded the worst performance at -9.8% per year.
Loading...
Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
---|---|
2019 | 2.50 |
2018 | 3.20 |
2017 | 4.00 |
2016 | 3.90 |
2015 | 4.00 |
How does Norway rank in Antihypertensive Medicine Use?
# | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Hungary
|
35 | 2019 | +4.2 % | +4.2 % | View data | |
2 |
#2
Lithuania
|
24 | 2019 | +4.7 % | -3.6 % | View data | |
25 |
#25
Chile
|
3 | 2019 | +23.8 % | +1.6 % | View data | |
26 |
#26
Norway
|
3 | 2019 | -21.9 % | -9.4 % | View data | |
27 |
#27
South Korea
|
2 | 2019 | -5.3 % | -4.8 % | View data |